• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简化阴性和阳性症状访谈获得的六项目正负症状量表评分的临床验证。

Clinical validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview.

机构信息

Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

出版信息

J Psychopharmacol. 2021 Sep;35(9):1081-1090. doi: 10.1177/0269881121996890. Epub 2021 Mar 28.

DOI:10.1177/0269881121996890
PMID:33779360
Abstract

BACKGROUND

The six-item version of the Positive and Negative Syndrome Scale (PANSS-6) has shown promise as a brief measure of the severity of core symptoms of schizophrenia. However, since all prior analyses of the PANSS-6 were based on data extracted from studies using the full 30-item PANSS (PANSS-30), it remains unknown whether it is possible to obtain valid information for the PANSS-6 ratings via a brief interview, such as the Simplified Negative and Positive Symptoms Interview (SNAPSI).

AIMS

We aimed to validate the PANSS-6 ratings obtained via the SNAPSI using the PANSS-6 scores extracted from the PANSS-30 ratings obtained via the comprehensive Structured Clinical Interview for PANSS (SCI-PANSS) as the gold-standard reference.

METHODS

The PANSS-6 ratings based on the SNAPSI and the PANSS-30 ratings based on the SCI-PANSS were conducted by independent raters with established inter-rater reliability.

RESULTS

Seventy-seven inpatients with schizophrenia ( = 35.1 ± 11.7 years; males = 57%; paranoid schizophrenia = 75%) participated in the study. The intraclass correlation coefficient (ICC) of the PANSS-6 total scores obtained using the SNAPSI and the PANSS-30-derived PANSS-6 total scores via the SCI-PANSS was 0.77 ( < 0.001). The ICC for the PANSS-6 total score and the PANSS-30-derived PANSS-8 (Andreasen's remission criteria) was 0.75 ( < 0.001). Spearman's rank correlation coefficient for changes in PANSS-6 total scores via the SNAPSI and changes in PANSS-30-derived PANSS-6 total scores was 0.70 ( < 0.001).

CONCLUSIONS

Using the SNAPSI to rate the PANSS-6 enables a focused and brief assessment of the severity of core symptoms of schizophrenia, which facilitates measurement-based care and clinical decision making in the treatment of schizophrenia.

摘要

背景

阳性与阴性症状量表(PANSS)的六分量表版(PANSS-6)已被证明是一种评估精神分裂症核心症状严重程度的简短工具。然而,由于之前所有对 PANSS-6 的分析都是基于从使用完整的 30 项 PANSS(PANSS-30)的研究中提取的数据进行的,因此仍然不清楚是否可以通过简短的访谈(如简化的阳性与阴性症状量表访谈(SNAPSI))获得 PANSS-6 评分的有效信息。

目的

我们旨在通过使用基于全面结构化临床访谈 PANSS(SCI-PANSS)的 PANSS-30 评分提取的 PANSS-6 评分作为金标准参考,来验证通过 SNAPSI 获得的 PANSS-6 评分。

方法

由具有可靠内部一致性的独立评估者进行基于 SNAPSI 的 PANSS-6 评分和基于 SCI-PANSS 的 PANSS-30 评分。

结果

共有 77 名住院精神分裂症患者(年龄=35.1±11.7 岁;男性=57%;偏执型精神分裂症=75%)参与了这项研究。使用 SNAPSI 获得的 PANSS-6 总分的组内相关系数(ICC)与通过 SCI-PANSS 从 PANSS-30 衍生的 PANSS-6 总分的 ICC 为 0.77(<0.001)。PANSS-6 总分与 PANSS-30 衍生的 PANSS-8(Andreasen 缓解标准)的 ICC 为 0.75(<0.001)。通过 SNAPSI 获得的 PANSS-6 总分的变化与通过 SCI-PANSS 从 PANSS-30 衍生的 PANSS-6 总分的变化之间的 Spearman 秩相关系数为 0.70(<0.001)。

结论

使用 SNAPSI 对 PANSS-6 进行评分,可以对精神分裂症核心症状的严重程度进行重点和简短的评估,这有助于在精神分裂症的治疗中进行基于测量的护理和临床决策。

相似文献

1
Clinical validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview.简化阴性和阳性症状访谈获得的六项目正负症状量表评分的临床验证。
J Psychopharmacol. 2021 Sep;35(9):1081-1090. doi: 10.1177/0269881121996890. Epub 2021 Mar 28.
2
Inter-rater reliability of ratings on the six-item Positive and Negative Syndrome Scale (PANSS-6) obtained using the Simplified Negative and Positive Symptoms Interview (SNAPSI).使用简化正负症状访谈(SNAPSI)获得的六项阳性和阴性症状量表(PANSS-6)评分的评分者间信度。
Nord J Psychiatry. 2018 Aug;72(6):431-436. doi: 10.1080/08039488.2018.1492014. Epub 2018 Jul 24.
3
Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia.验证通过简化阴性和阳性症状访谈获得的六项目正负症状量表在门诊精神分裂症患者中的评分。
J Psychopharmacol. 2022 Nov;36(11):1208-1217. doi: 10.1177/02698811221131992. Epub 2022 Oct 21.
4
Bridging the Measurement Gap Between Research and Clinical Care in Schizophrenia: Positive and Negative Syndrome Scale-6 (PANSS-6) and Other Assessments Based on the Simplified Negative and Positive Symptoms Interview (SNAPSI).弥合精神分裂症研究与临床护理之间的测量差距:阳性和阴性症状量表-6(PANSS-6)以及基于简化阴性和阳性症状访谈(SNAPSI)的其他评估
Innov Clin Neurosci. 2017 Dec 1;14(11-12):68-72.
5
Standardized training in the rating of the six-item Positive And Negative Syndrome Scale (PANSS-6).六项目阳性和阴性症状量表(PANSS-6)评定的标准化培训。
Schizophr Res. 2021 Feb;228:438-446. doi: 10.1016/j.schres.2020.12.044. Epub 2021 Feb 9.
6
Use of video-recordings of site-based interviews for quality assurance in a study of subjects with schizophrenia and persistent negative symptoms.使用基于现场访谈的视频记录进行质量保证,以研究患有精神分裂症和持续性阴性症状的受试者。
Schizophr Res. 2024 Oct;272:61-68. doi: 10.1016/j.schres.2024.08.014. Epub 2024 Aug 26.
7
The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity.阳性与阴性症状量表及简明精神病评定量表。信度、可比性及预测效度。
J Nerv Ment Dis. 1992 Nov;180(11):723-8. doi: 10.1097/00005053-199211000-00007.
8
The Validity and Sensitivity of PANSS-6 in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study.PANSS-6 在干预有效性临床抗精神病药物试验 (CATIE) 研究中的有效性和敏感性。
Schizophr Bull. 2018 Feb 15;44(2):453-462. doi: 10.1093/schbul/sbx076.
9
Interrater reliability of the Structured Clinical Interview for the Positive and Negative Syndrome Scale for schizophrenia.精神分裂症阳性和阴性症状量表结构化临床访谈的评分者间信度。
Acta Psychiatr Scand. 1994 Mar;89(3):192-5. doi: 10.1111/j.1600-0447.1994.tb08091.x.
10
Polish version of the Brief Negative Symptom Scale (BNSS).简明阴性症状量表(BNSS)波兰语版本。
Psychiatr Pol. 2019 Jun 30;53(3):541-549. doi: 10.12740/PP/OnlineFirst/91490.

引用本文的文献

1
Risperidone ISM: review and update of its usefulness in all phases of schizophrenia.利培酮个体稳态模型:对其在精神分裂症各阶段效用的综述与更新
Ther Adv Psychopharmacol. 2024 Oct 4;14:20451253241280046. doi: 10.1177/20451253241280046. eCollection 2024.
2
Treatment of schizophrenia evaluated via the pharmacopsychometric triangle-An integrative approach with emphasis on well-being and functioning.通过药物心理测量三角评估精神分裂症的治疗——一种强调幸福感和功能的综合方法。
Schizophrenia (Heidelb). 2023 Dec 16;9(1):88. doi: 10.1038/s41537-023-00420-6.
3
Are informants required to obtain valid ratings on the Positive and Negative Syndrome Scale (PANSS)?
是否要求提供信息者获得阳性和阴性症状量表(PANSS)的有效评分?
Schizophrenia (Heidelb). 2023 Aug 31;9(1):54. doi: 10.1038/s41537-023-00378-5.
4
Initial severity of the Positive and Negative Syndrome Scale (PANSS)-30, its main subscales plus the PANSS-6, and the relationship to subsequent improvement and trial dropout: a pooled participant-level analysis of 18 placebo-controlled risperidone and paliperidone trials.阳性和阴性症状量表(PANSS)-30、其主要子量表加 PANSS-6 的初始严重程度,以及与随后的改善和试验脱落的关系:18 项安慰剂对照利培酮和帕利哌酮试验的汇总参与者水平分析。
Transl Psychiatry. 2023 Jun 7;13(1):191. doi: 10.1038/s41398-023-02491-6.
5
A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia.治疗抵抗性精神分裂症患者氯氮平治疗启动和管理的指南和检查表。
CNS Drugs. 2022 Jul;36(7):659-679. doi: 10.1007/s40263-022-00932-2. Epub 2022 Jun 27.